[1] | Mims, J.W. (2015) Asthma: Definitions and Pathophysiology. International Forum of Allergy & Rhinology, 5, S2-S6. https://doi.org/10.1002/alr.21609 |
[2] | (2020) Global Burden of 369 Diseases and Injuries in 204 Countries and Territories, 1990-2019: A Systematic Analysis for the Global Burden of Disease Study 2019. The Lancet, 396, 1204-1222. |
[3] | 林江涛, 王文巧, 周新, 等. 我国30个省市城区门诊支气管哮喘患者控制水平的调查结果[J]. 中华结核和呼吸杂志, 2017, 40(7): 494-498. |
[4] | Roden, D.M., McLeod, H.L., Relling, M.V., et al. (2019) Pharmacogenomics. The Lancet, 394, 521-532. https://doi.org/10.1016/S0140-6736(19)31276-0 |
[5] | Turner, S., Francis, B., Vijverberg, S., et al. (2016) Childhood Asthma Exacerbations and the Arg16 β2-Receptor Polymorphism: A Meta-Analysis Stratified by Treatment. Journal of Allergy and Clinical Immunology, 138, 107-113.E5. https://doi.org/10.1016/j.jaci.2015.10.045 |
[6] | Ober, C. and Yao, T.C. (2011) The Genetics of Asthma and Allergic Disease: A 21st Century Perspective. Immunological Reviews, 242, 10-30. https://doi.org/10.1111/j.1600-065X.2011.01029.x |
[7] | Dehghan, A. (2018) Genome-Wide Association Studies. Methods in Molecular Biology, 1793, 37-49. https://doi.org/10.1007/978-1-4939-7868-7_4 |
[8] | Adikusuma, W., Chou, W.H., Lin, M.R., et al. (2022) Identification of Druggable Genes for Asthma by Integrated Genomic Network Analysis. Biomedicines, 10, Article No. 113. https://doi.org/10.3390/biomedicines10010113 |
[9] | Barnes, P.J., Greening, A.P. and Crompton, G.K. (1995) Glucocorticoid Resistance in Asthma. American Journal of Respiratory and Critical Care Medicine, 152, S125-S140. https://doi.org/10.1164/ajrccm/152.6_Pt_2.S125 |
[10] | Henderson, I., Caiazzo, E., McSharry, C., et al. (2020) Why Do Some Asthma Patients Respond Poorly to Glucocorticoid Therapy? Pharmacological Research, 160, Article ID: 105189. https://doi.org/10.1016/j.phrs.2020.105189 |
[11] | Tantisira, K.G., Lasky-Su, J., Harada, M., et al. (2011) Genomewide Association between GLCCI1 and Response to Glucocorticoid Therapy in Asthma. The New England Journal of Medicine, 365, 1173-1183. https://doi.org/10.1056/NEJMoa0911353 |
[12] | Tantisira, K.G., Damask, A., Szefler, S.J., et al. (2012) Genome-Wide Association Identifies the T Gene as a Novel Asthma Pharmacogenetic Locus. American Journal of Respiratory and Critical Care Medicine, 185, 1286-1291. https://doi.org/10.1164/rccm.201111-2061OC |
[13] | Park, H.W., Dahlin, A., Tse, S., et al. (2014) Genetic Predictors Associated with Improvement of Asthma Symptoms in Response to Inhaled Corticosteroids. Journal of Allergy and Clinical Immunology, 133, 664-669.E5. https://doi.org/10.1016/j.jaci.2013.12.1042 |
[14] | Wu, A.C., Himes, B.E., Lasky-Su, J., et al. (2014) Inhaled Corticosteroid Treatment Modulates ZNF432 Gene Variant’s Effect on Bronchodilator Response in Asthmatics. Journal of Allergy and Clinical Immunology, 133, 723-728.E3. https://doi.org/10.1016/j.jaci.2013.09.037 |
[15] | Dahlin, A., Denny, J., Roden, D.M., et al. (2015) CMTR1 Is Associated with Increased Asthma Exacerbations in Patients Taking Inhaled Corticosteroids. Immunity, Inflammation and Disease, 3, 350-359. https://doi.org/10.1002/iid3.73 |
[16] | Mosteller, M., Hosking, L., Murphy, K., et al. (2017) No Evidence of Large Genetic Effects on Steroid Response in Asthma Patients. Journal of Allergy and Clinical Immunology, 139, 797-803.E7. https://doi.org/10.1016/j.jaci.2016.05.032 |
[17] | Hernandez-Pacheco, N., Farzan, N., Francis, B., et al. (2019) Genome-Wide Association Study of Inhaled Corticosteroid Response in Admixed Children with Asthma. Clinical & Experimental Allergy, 49, 789-798. https://doi.org/10.1111/cea.13354 |
[18] | Hernandez-Pacheco, N., Vijverberg, S.J., Herrera-Luis, E., et al. (2021) Genome-Wide Association Study of Asthma Exacerbations despite Inhaled Corticosteroid Use. European Respiratory Journal, 57, Article ID: 2003388. |
[19] | Park, T.J., Park, J.S., Cheong, H.S., et al. (2014) Genome-Wide Association Study Identifies ALLC Polymorphisms Correlated with FEV1 Change by Corticosteroid. Clinica Chimica Acta, 436, 20-26. https://doi.org/10.1016/j.cca.2014.04.023 |
[20] | Wang, Y., Tong, C., Wang, Z., et al. (2015) Pharmacodynamic Genome-Wide Association Study Identifies New Responsive Loci for Glucocorticoid Intervention in Asthma. The Pharmacogenomics Journal, 15, 422-429. https://doi.org/10.1038/tpj.2014.83 |
[21] | Finkelstein, Y., Bournissen, F.G., Hutson, J.R., et al. (2009) Polymorphism of the ADRB2 Gene and Response to Inhaled Beta-Agonists in Children with Asthma: A Meta-Analysis. Journal of Asthma, 46, 900-905. https://doi.org/10.3109/02770900903199961 |
[22] | Poon, A.H., Tantisira, K.G., Litonjua, A.A., et al. (2008) Association of Corticotropin-Releasing Hormone Receptor-2 Genetic Variants with Acute Bronchodilator Response in Asthma. Pharmacogenetics and Genomics, 18, 373-382. https://doi.org/10.1097/FPC.0b013e3282fa760a |
[23] | Dragicevic, S., Kosnik, M., Divac Rankov, A., et al. (2018) The Variants in the 3’ Untranslated Region of the Matrix Metalloproteinase 9 Gene as Modulators of Treatment Outcome in Children with Asthma. Lung, 196, 297-303. https://doi.org/10.1007/s00408-018-0113-y |
[24] | Litonjua, A.A., Lasky-Su, J., Schneiter, K., et al. (2008) ARG1 Is a Novel Bronchodilator Response Gene: Screening and Replication in Four Asthma Cohorts. American Journal of Respiratory and Critical Care Medicine, 178, 688-694. https://doi.org/10.1164/rccm.200709-1363OC |
[25] | Himes, B.E., Jiang, X., Hu, R., et al. (2012) Genome-Wide Association Analysis in Asthma Subjects Identifies SPATS2L as a Novel Bronchodilator Response Gene. PLOS Genetics, 8, E1002824. https://doi.org/10.1371/journal.pgen.1002824 |
[26] | Duan, Q.L., Lasky-Su, J., Himes, B.E., et al. (2014) A Genome-Wide Association Study of Bronchodilator Response in Asthmatics. The Pharmacogenomics Journal, 14, 41-47. https://doi.org/10.1038/tpj.2013.5 |
[27] | Israel, E., Lasky-Su, J., Markezich, A., et al. (2015) Genome-Wide Association Study of Short-Acting β2-Agonists. A Novel Genome-Wide Significant Locus on Chromosome 2 near ASB3. American Journal of Respiratory and Critical Care Medicine, 191, 530-537. https://doi.org/10.1164/rccm.201408-1426OC |
[28] | Drake, K.A., Torgerson, D.G., Gignoux, C.R., et al. (2014) A Genome-Wide Association Study of Bronchodilator Response in Latinos Implicates Rare Variants. Journal of Allergy and Clinical Immunology, 133, 370-378. https://doi.org/10.1016/j.jaci.2013.06.043 |
[29] | Padhukasahasram, B., Yang, J.J., Levin, A.M., et al. (2014) Gene-Based Association Identifies SPATA13-AS1 as a Pharmacogenomic Predictor of Inhaled Short-Acting Beta-Agonist Response in Multiple Population Groups. The Pharmacogenomics Journal, 14, 365-371. https://doi.org/10.1038/tpj.2013.49 |
[30] | Spear, M.L., Hu, D., Pino-Yanes, M., et al. (2019) A Genome-Wide Association and Admixture Mapping Study of Bronchodilator Drug Response in African Americans with Asthma. The Pharmacogenomics Journal, 19, 249-259. https://doi.org/10.1038/s41397-018-0042-4 |
[31] | Mak, A., White, M.J., Eckalbar, W.L., et al. (2018) Whole-Genome Sequencing of Pharmacogenetic Drug Response in Racially Diverse Children with Asthma. American Journal of Respiratory and Critical Care Medicine, 197, 1552-1564. https://doi.org/10.1164/rccm.201712-2529OC |
[32] | Perez-Garcia, J., Espuela-Ortiz, A., Lorenzo-Diaz, F., et al. (2020) Pharmacogenetics of Pediatric Asthma: Current Perspectives. Pharmacogenomics and Personalized Medicine, 13, 89-103. https://doi.org/10.2147/PGPM.S201276 |
[33] | GINA Executive and Science Committee (2023) Global Strategy for Asthma Management and Prevention 2023. http://www.gina.com |
[34] | Reddel, H.K., Bacharier, L.B., Bateman, E.D., et al. (2022) Global Initiative for Asthma Strategy 2021: Executive Summary and Rationale for Key Changes. European Respiratory Journal, 59, Article ID: 2102730. https://doi.org/10.1183/13993003.02730-2021 |
[35] | Zuurhout, M.J., Vijverberg, S.J., Raaijmakers, J.A., Koenderman, L., Postma, D.S., Koppelman, G.H. and Maitland-van der Zee, A.H. (2013) Arg16 ADRB2 Genotype Increases the Risk of Asthma Exacerbation in Children with a Reported Use of Long-Acting β2-Agonists: Results of the PACMAN Cohort. Pharmacogenomics, 14, 1965-1971. https://doi.org/10.2217/pgs.13.200 |
[36] | Kim, S.H., Ye, Y.M., Lee, H.Y., et al. (2011) Combined Pharmacogenetic Effect of ADCY9 and ADRB2 Gene Polymorphisms on the Bronchodilator Response to Inhaled Combination Therapy. Journal of Clinical Pharmacy and Therapeutics, 36, 399-405. https://doi.org/10.1111/j.1365-2710.2010.01196.x |
[37] | Liang, S., Wei, X., Gong, C., et al. (2013) A Disintegrin and Metalloprotease 33 (ADAM33) Gene Polymorphisms and the Risk of Asthma: A Meta-Analysis. Human Immunology, 74, 648-657. https://doi.org/10.1016/j.humimm.2013.01.025 |
[38] | Slob, E., Richards, L.B., Vijverberg, S., et al. (2021) Genome-Wide Association Studies of Exacerbations in Children Using Long-Acting Beta2-Agonists. Pediatric Allergy and Immunology, 32, 1197-1207. https://doi.org/10.1111/pai.13494 |
[39] | Farzan, N., Vijverberg, S.J., Arets, H.G., et al. (2017) Pharmacogenomics of Inhaled Corticosteroids and Leukotriene Modifiers: A Systematic Review. Clinical & Experimental Allergy, 47, 271-293. https://doi.org/10.1111/cea.12844 |
[40] | Dahlin, A., Litonjua, A., Irvin, C.G., et al. (2016) Genome-Wide Association Study of Leukotriene Modifier Response in Asthma. The Pharmacogenomics Journal, 16, 151-157. https://doi.org/10.1038/tpj.2015.34 |
[41] | 朱桂萍, 叶伶, 金美玲. 支气管哮喘靶向治疗的研究进展[J]. 国际呼吸杂志, 2021, 41(7): 529-535. |
[42] | El-Husseini, Z.W., Gosens, R., Dekker, F., et al. (2020) The Genetics of Asthma and the Promise of Genomics-Guided Drug Target Discovery. The Lancet Respiratory Medicine, 8, 1045-1056. https://doi.org/10.1016/S2213-2600(20)30363-5 |
[43] | Chapman, M.S., Askew, D.J., Kuscuoglu, U., et al. (1996) Transcriptional Control of Steroid-Regulated Apoptosis in Murine Thymoma Cells. Molecular Endocrinology, 10, 967-978. https://doi.org/10.1210/mend.10.8.8843413 |
[44] | Hu, C., Xun, Q., Li, X., et al. (2016) GLCCI1 Variation Is Associated with Asthma Susceptibility and Inhaled Corticosteroid Response in a Chinese Han Population. Archives of Medical Research, 47, 118-125. https://doi.org/10.1016/j.arcmed.2016.04.005 |
[45] | Izuhara, Y., Matsumoto, H., Kanemitsu, Y., et al. (2014) GLCCI1 Variant Accelerates Pulmonary Function Decline in Patients with Asthma Receiving Inhaled Corticosteroids. Allergy, 69, 668-673. https://doi.org/10.1111/all.12400 |
[46] | Hikino, K., Kobayashi, S., Ota, E., et al. (2021) A Meta-Analysis of the Influence of ADRB2 Genetic Polymorphisms on Albuterol (Salbutamol) Therapy in Patients with Asthma. British Journal of Clinical Pharmacology, 87, 1708-1716. https://doi.org/10.1111/bcp.14570 |
[47] | Slob, E., Vijverberg, S., Palmer, C., et al. (2018) Pharmacogenetics of Inhaled Long-Acting Beta2-Agonists in Asthma: A Systematic Review. Pediatric Allergy and Immunology, 29, 705-714. https://doi.org/10.1111/pai.12956 |
[48] | Ortega, V.E. and Meyers, D.A. (2014) Pharmacogenetics: Implications of Race and Ethnicity on Defining Genetic Profiles for Personalized Medicine. Journal of Allergy and Clinical Immunology, 133, 16-26. https://doi.org/10.1016/j.jaci.2013.10.040 |
[49] | Cazzola, M., Calzetta, L., Matera, M.G., et al. (2018) How Does Race/Ethnicity Influence Pharmacological Response to Asthma Therapies? Expert Opinion on Drug Metabolism & Toxicology, 14, 435-446. https://doi.org/10.1080/17425255.2018.1449833 |
[50] | Tam, V., Patel, N., Turcotte, M., et al. (2019) Benefits and Limitations of Genome-Wide Association Studies. Nature Reviews Genetics, 20, 467-484. https://doi.org/10.1038/s41576-019-0127-1 |